Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Is a |
Product containing nafarelin (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Nafarelin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Is a |
Nafarelin acetate preparation |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Nafarelin acetate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Synthetic hormone agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Gonadotropin |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Is a |
Product containing nafarelin acetate in nasal dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has manufactured dose form |
Nasal dose form (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has manufactured dose form |
Nasal spray |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Is a |
Product containing nafarelin in nasal dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has basis of strength substance (attribute) |
Nafarelin (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength numerator unit (attribute) |
mcg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has precise active ingredient |
Nafarelin acetate |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength numerator value |
200 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength denominator unit (attribute) |
Actuation (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has unit of presentation |
Actuation (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Count of base of active ingredient |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) |
Is a |
Nafarelin only product in nasal dose form |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|